Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,547 | 133 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $420.22 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $274.49 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $252.36 | 16 | $0 (2024) |
| ViiV Healthcare Company | $226.32 | 11 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $144.97 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $139.52 | 8 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $91.01 | 5 | $0 (2023) |
| Azurity Pharmaceuticals, Inc. | $82.87 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $79.69 | 4 | $0 (2022) |
| PFIZER INC. | $69.96 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $886.78 | 46 | Novo Nordisk Inc ($192.38) |
| 2023 | $689.22 | 35 | Novartis Pharmaceuticals Corporation ($116.70) |
| 2022 | $425.77 | 23 | Novo Nordisk Inc ($97.53) |
| 2021 | $545.18 | 29 | ViiV Healthcare Company ($226.32) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: ANTI-DIABETIC | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: VACCINES | ||||||
| 10/05/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ANTI-DIABETIC | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Obesity | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 50 | 55 | $16,005 | $2,207 |
| 2022 | 8 | 524 | 712 | $151,020 | $42,769 |
| 2021 | 9 | 479 | 651 | $122,105 | $39,449 |
| 2020 | 7 | 332 | 470 | $65,675 | $18,464 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 22 | $7,920 | $1,257 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 33 | $8,085 | $950.13 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 176 | 255 | $62,475 | $17,104 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 180 | $64,800 | $15,800 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $16,440 | $6,247 | 38.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $2,255 | $1,851 | 82.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 36 | $2,545 | $1,274 | 50.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 96 | 145 | $2,175 | $427.35 | 19.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 11 | 11 | $220.00 | $41.57 | 18.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 11 | $110.00 | $24.45 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 173 | $53,800 | $16,432 | 30.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 193 | $41,660 | $13,003 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $15,825 | $6,477 | 40.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 30 | 32 | $4,160 | $1,642 | 39.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $960.00 | $783.12 | 81.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $1,540 | $448.36 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 92 | 140 | $2,100 | $417.00 | 19.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 18 | $1,800 | $199.84 | 11.1% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 12 | 13 | $260.00 | $46.80 | 18.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 94 | $24,840 | $7,085 | 28.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 104 | 150 | $27,845 | $6,969 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $6,550 | $2,721 | 41.5% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 20 | 20 | $900.00 | $584.60 | 65.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $1,610 | $454.25 | 28.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 80 | 142 | $2,130 | $419.25 | 19.7% |
About Bernadette Dube
Bernadette Dube is a Family healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891114773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bernadette Dube has received a total of $2,547 in payments from pharmaceutical and medical device companies, with $886.78 received in 2024. These payments were reported across 133 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,547).
As a Medicare-enrolled provider, Dube has provided services to 1,385 Medicare beneficiaries, totaling 1,888 services with total Medicare billing of $102,889. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Northport, NY
- Active Since 04/08/2014
- Last Updated 04/08/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891114773
Products in Payments
- DOVATO (Drug) $226.32
- LEQVIO (Drug) $198.61
- Wegovy (Drug) $152.15
- XARELTO (Drug) $139.52
- Livalo (Drug) $131.29
- NUZYRA (Drug) $91.01
- Rybelsus (Drug) $87.99
- CYCLOSET (Drug) $80.59
- VERQUVO (Drug) $76.52
- Repatha (Biological) $65.01
- Ozempic (Drug) $63.69
- GARDASIL (Biological) $61.14
- FARXIGA (Drug) $59.56
- DIFICID (Drug) $58.43
- Heplisav-B (Drug) $56.37
- Saxenda (Drug) $54.10
- ENTRESTO (Drug) $53.75
- PREVNAR 20 (Biological) $50.72
- FUROSCIX (Drug) $49.34
- INJECTAFER (Drug) $47.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Northport
Mrs. Lauren Perkins, Crnp, CRNP
Family — Payments: $16,223
Staci Hardwick, Fnp-Bc, FNP-BC
Family — Payments: $9,103
Mary Jordan Armstrong
Family — Payments: $6,651
Shelby Warren, Np, NP
Family — Payments: $4,509
Mrs. Emily Jones, Np, NP
Family — Payments: $4,175
Karlie Ryan
Family — Payments: $3,782